It was reported that during a routine change of this cleo® 90 infusion set, the cannula of the device was found to be lodged beneath the skin.The patient's blood glucose levels were noted to be approximately 450 mg/dl at peak.The patient inserted a new site and successfully resumed infusion.Initially, the patient was advised by a healthcare professional to leave the cannula under the skin in anticipation that the body's inflammation response would release the cannula.This condition remained ongoing, and the patient was admitted to the hospital for surgical removal of the lodged cannula.Surgical intervention resolved the issue, and the patient was discharged three days later.The healthcare professional believed that the cause of this occurrence could be attributed to bacteria and an "unclean site." no other adverse patient effects were reported.
|